Engineered macrophages can enhance tumor immunotherapy! This study shows that expanding granulocyte-monocyte progenitors (GMPs) ex vivo is possible, maintaining their identity and potential. Key finding… PMID:42320470, Cell 2026, @Cell https://www.cell.co…
RP @shihcheng.bsky.social: Engineered macrophages show promise for tumor immunotherapy but face challenges. This study reveals long-term expansion of GMPs (up to x-fold) while maintaining progenitor identity, identifying myeloperoxidase… PMID:42320470, Ce…
Engineered macrophages show promise for tumor immunotherapy but face challenges. This study reveals long-term expansion of GMPs (up to x-fold) while maintaining progenitor identity, identifying myeloperoxidase… PMID:42320470, Cell 2026, @Cell https://www.…
RP @shihcheng.bsky.social: Engineered macrophages show promise in tumor immunotherapy but face limitations. This study reveals that optimized culture conditions enable long-term expansion of mouse and human granulocyte-monocyte… PMID:42320470, Cell 2026, …